Novacyt strengthens board

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics is pleased to announce the addition of new members to its Board as the Company prepares for the next stages of growth. Download press release

Visit Page

Novacyt launches molecular HPV service to its NOVAPREP® customers

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics has launched a molecular HPV (Human Papillomavirus) service for all its customers who currently use its next generation NOVAprep® liquid-based cytology platform for cervical cancer screening. Download press release

Visit Page

Novacyt and Leica Biosystems launch NOVAPREP® in China

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics and Leica Biosystems, a leading supplier to the pathology market, today announce the start of the sales and marketing programme for the launch of the NOVAprep® platform in China. Download press release

Visit Page